Biotrin International - Company Logo



 
  Product information
 

 
Parvovirus B19 IgG EIA * (FDA Approved)

CODE: V519IGUS
Assay Format: 96 well EIA
Last updated
4th August 2010


* For sale in the U.S.A only

INTENDED USE

An in vitro enzyme immunoassay for the detection of anti-Parvovirus IgG B19 antibodies in human serum and plasma.

ASSAY PRINCIPLE

The Biotrin International Parvovirus B19 IgG Enzyme Immunoassay is a sandwich enzyme immunoassay for the detection of IgG class antibodies to Parvovirus B19 in human serum and plasma. Specific Parvovirus B19 IgG antibodies, present in serum or plasma will bind to the microassay wells coated with a purified parvovirus B19 recombinant VP2 protein. Following a wash step, peroxidase-labelled rabbit antihuman IgG is added which binds to the human Parvovirus B19 IgG present. The whole complex is then detected by addition of substrate (TMB) which turns blue in the presence of peroxidase. A stable yellow end product is achieved by the addition of a stopping reagent.

Biotrin Parvovirus B19 IgG EIA (U.S.A FDA Cleared) Instructions for Use

Product DescriptionFormatCatalogue No.
Parvovirus B19 IgG (mu capture) EIA*96 well EIAV519IGUS

 
 
If you would like more information, please fill out our  

 

 
 
   
© 2005 Biotrin International
For further information on Fifth Disease click here
Website Design by Net Affinity

93 The Rise, Mount Merrion, Co. Dublin, Ireland.
Tel: +353 1 283 1166 | Fax: +353 1 283 1232
Email: info@biotrin.ie
For technical support please email: customercare@biotrin.ie
Company No. 422701